Human milk oligosaccharides regulate human macrophage polarization and activation in response to Staphylococcus aureus

Human milk oligosaccharides (HMOs) are present in high numbers in milk of lactating women. They are beneficial to gut health and the habitant microbiota, but less is known about their effect on cells from the immune system. In this study, we investigated the direct effect of three structurally diffe...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Stine Dam Jepsen, Astrid Lund, Martin Matwiejuk, Lars Andresen, Kristine Rothaus Christensen, Søren Skov
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-06-01
Subjects:	human milk oligosaccharides myeloid activation immunology 6′-sialyllactose 2′-fucosyllactose lacto-N-neotetraose
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1379042/full

Similar Items

Bovine Milk Oligosaccharides and Human Milk Oligosaccharides Modulate the Gut Microbiota Composition and Volatile Fatty Acid Concentrations in a Preclinical Neonatal Model
by: Mei Wang, et al.
Published: (2021-04-01)

Formula supplementation with human and bovine milk oligosaccharides modulates blood IgG and T-helper cell populations, and ex vivo LPS-stimulated cytokine production in a neonatal preclinical model
by: Marcia H. Monaco, et al.
Published: (2023-12-01)

Statement on the safety of lacto‐N‐neotetraose and 2′‐O‐fucosyllactose as novel food ingredients in food supplements for children
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2015-11-01)

Real-world evidence study on tolerance and growth in infants fed an infant formula with two human milk oligosaccharides vs mixed fed and exclusively breastfed infants
by: Frank Jochum, et al.
Published: (2023-08-01)

Biochemical characterization of a novel C-terminally truncated β-galactosidase from Paenibacillus antarcticus with high transglycosylation activity
by: Jing Li, et al.
Published: (2024-12-01)

Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers
by: Jessica Ramadhin, et al.
Published: (2020-09-01)

Ameliorating effect of 2′-fucosyllactose and 6′-sialyllactose on lipopolysaccharide-induced intestinal inflammation
by: J.-Y. Kim, et al.
Published: (2024-07-01)

Anti-Angiogenic Property of Free Human Oligosaccharides
by: Boram Bae, et al.
Published: (2021-05-01)

2′FL and LNnT Exert Antipathogenic Effects against <i>C. difficile</i> ATCC 9689 In Vitro, Coinciding with Increased Levels of <i>Bifidobacteriaceae</i> and/or Secondary Bile Acids
by: Louise Kristine Vigsnaes, et al.
Published: (2021-07-01)

Rational Design of a Truncated β-Galactosidase from Bacillus sp. and Its Application in the Synthesis of Lacto-N-neotetraose
by: Jianyu WANG, et al.
Published: (2025-09-01)

Strategies for synthesizing human milk lacto-N-fucopentaoses oligosaccharides
by: Minjiao Zhang, et al.
Published: (2023-12-01)

Sialyllactose Enhances the Short-Chain Fatty Acid Production and Barrier Function of Gut Epithelial Cells via Nonbifidogenic Modification of the Fecal Microbiome in Human Adults
by: Yohei Sato, et al.
Published: (2024-01-01)

Analysis of twelve human milk oligosaccharides over fifteen months post-partum in human milk from Chinese mothers
by: Yibing Ning, et al.
Published: (2024-10-01)

Structural Characterization and Abundance of Sialylated Milk Oligosaccharides in Holstein Cows during Early Lactation
by: Lisa Isernhagen, et al.
Published: (2024-08-01)

Safety of lacto‐N‐fucopentaose I/2’‐fucosyllactose (LNFP‐I/2’‐FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-12-01)

The synergies effect of 3′-sialyllactose and 2′-fucosyllactose on the attenuation of food allergy symptoms in a mouse model
by: Lina Zhang, et al.
Published: (2024-09-01)

Chemoenzymatic Synthesis of Asymmetrically Branched Human Milk Oligosaccharide Lacto-N-Hexaose
by: Kai-Eng Ooi, et al.
Published: (2022-05-01)

Non-Targeted Metabolomics of White Rhinoceros Colostrum and Its Changes During Early Lactation by <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy
by: Gernot Osthoff, et al.
Published: (2024-11-01)

Human milk oligosaccharides in infant formula: yesterday, today, tomorrow
by: I. V. Gmoshinsky, et al.
Published: (2022-02-01)

The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
by: Patricia Sanz Morales, et al.
Published: (2022-11-01)

Combining 2′-fucosyllactose and galacto-oligosaccharides exerts anti-inflammatory effects and promotes gut health
by: Sewon Park, et al.
Published: (2024-12-01)

Infant Fecal Fermentations with Galacto-Oligosaccharides and 2′-Fucosyllactose Show Differential <i>Bifidobacterium longum</i> Stimulation at Subspecies Level
by: Cordula Lindner, et al.
Published: (2023-02-01)

Modulating the developing gut microbiota with 2’-fucosyllactose and pooled human milk oligosaccharides
by: Simone Renwick, et al.
Published: (2025-02-01)

2′-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids
by: Ketki Patil, et al.
Published: (2025-02-01)

The Effect of Human Milk Oligosaccharides and <i>Bifidobacterium longum</i> subspecies <i>infantis</i> Bi-26 on Simulated Infant Gut Microbiome and Metabolites
by: Krista Salli, et al.
Published: (2023-06-01)

A human milk oligosaccharide prevents intestinal inflammation in adulthood via modulating gut microbial metabolism
by: Kasey M. Schalich, et al.
Published: (2024-04-01)

Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model
by: Ulvi K. Gürsoy, et al.
Published: (2021-06-01)

Safety of the extension of use of 2’‐fucosyllactose/difucosyllactose (2’‐FL/DFL) mixture and lacto‐N‐tetraose (LNT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2022-03-01)

Enzymatic Cascades for Tailored <sup>13</sup>C<sub>6</sub> and <sup>15</sup>N Enriched Human Milk Oligosaccharides
by: Thomas Fischöder, et al.
Published: (2019-09-01)

Enhancing immune regulation in vitro: the synergistic impact of 3′-sialyllactose and osteopontin in a nutrient blend following influenza virus infection
by: Zhengtao Guo, et al.
Published: (2024-02-01)

Biochemical characterization of a novel β-galactosidase from Lacticaseibacillus zeae and its application in synthesis of lacto-N-tetraose
by: Ting Li, et al.
Published: (2023-10-01)

Modular bioengineering of whole-cell catalysis for sialo-oligosaccharide production: coordinated co-expression of CMP-sialic acid synthetase and sialyltransferase
by: Sabine Schelch, et al.
Published: (2023-11-01)

Screening of Human Milk Oligosaccharide Combinations for Immunomodulatory Activity and Immunomodulatory Effects of Milk Formula Containing Them on Mice
by: MENG Liping, YANG Chang, XU Xiaomin, WANG Meihua, SHI Hanxu, YE Wanyun, LIU Siyuan, QIAN Wentao, LI Hongliang, XU Yajun
Published: (2025-06-01)

Safety of 3′‐sialyllactose (3′‐SL) sodium salt produced by a derivative strain (Escherichia coli NEO3) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-09-01)

Safety of 3’‐Sialyllactose (3’‐SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2020-05-01)

Influence of 2′-Fucosyllactose on the Microbiota Composition and Metabolic Activity of Fecal Cultures from Breastfed and Formula-Fed Infants at Two Months of Age
by: Alicja M. Nogacka, et al.
Published: (2021-07-01)

Dietary supplementation of 3′-sialyllactose or 6′-sialyllactose elicits minimal influence on cognitive and brain development in growing pigs
by: Rebecca K. Golden, et al.
Published: (2024-01-01)

The Impact of Human Milk Oligosaccharides on Antibiotic-Induced Microbial Dysbiosis and Gut Inflammation in Mice
by: Kristine Rothaus Christensen, et al.
Published: (2025-05-01)

Safety of 6′‐sialyllactose (6′‐SL) sodium salt produced by a derivative strain (Escherichia coli NEO6) of E. coli W (ATCC 9637) as a Novel Food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2023-06-01)

Determining the safety and efficacy of dietary supplementation with 3ˊ-sialyllactose or 6ˊ-sialyllactose on growth, tolerance, and brain sialic acid concentrations
by: Rebecca K. Golden, et al.
Published: (2023-10-01)